期刊文献+

斑马鱼高血脂模型在山青之片质量控制中的应用研究 被引量:9

Zebrafish-Based Biological Quality Control for Lipid Lowering Shanqingzhi Tablets
下载PDF
导出
摘要 目的:探讨斑马鱼高血脂模型在山青之片质量控制中的应用。方法:用高脂肪饮食诱导的斑马鱼高血脂模型对山青之片进行生物活性评价和质量稳定性检测。结果:斑马鱼高血脂模型作为降血脂药物生物学质量内控检测方法具有较好的可重复性(RSD为3.5%)及稳定性(RSD为3.6%);不同批号山青之片具有较好的质量稳定性,其血脂降低率平均值为60.8%(P<0.001),RSD为1.9%;同批次山青之片供试品溶液室温放置8 h以内质量稳定,血脂降低率平均值为60.5%(P<0.001),RSD为3.1%。结论:用斑马鱼高血脂模型评价中药山青之片的降血脂效果,方法快速、稳定可靠;应用斑马鱼模型建立中药的生物学质量标准有助于推动中药的现代化,值得尝试和推广。 Objective: To establish larval zebrafish-based biologically quality control standard for lipid lowering traditional chinese medicine shanqingzhi tablets. Methods : Biological activity / pharmaceutical effect and stability of shanqingzhi tablets were quantitative- ly assessed in a well-validated larval zebrafish hyperlipidemia model induced by feeding standardized high-fat food. Results: Larval ze-brafish hyperlipidemia model as a biological quality control standard for lipid lowering shanqingzhi tablets exhibited excellent reproduc- ibility ( RSD = 3.5% ) and stability ( RSD = 3.6% ). The preparations from a variety of batches demonstrated similar pharmaceutical activity that reduced blood lipid in larval zebrafish by 60. 8% ( RSD = 1.9% , P 〈 0. 001 ) after 40 hrs of drug treatment. The same batch of preparations were all stable for at least 8 hrs in room temperature and decreased zebrafish blood lipid by 60. 5% ( RSD = 3. 1%, P 〈 0. 001 ). Conclusion: Zebrafish hyperlipidemia model-based biological quality control for lipid lowering shanqingzhi tablets is a rapid, reliable, stable and reproducible method. Developing biological quality control standards for natural products may contribute to the modernization of the traditional chinese medicines.
出处 《中国药品标准》 CAS 2013年第4期255-259,共5页 Drug Standards of China
关键词 斑马鱼 高血脂 山青之片 中药 质量控制 生物学活性测定 zebrafish hyperlipidemia shanqingzhi tablets traditional chinese medicine quality control biology activity assay
  • 相关文献

参考文献16

  • 1李波,朴晋华.中药生物活性质量控制的思考[J].中国药品标准,2012,13(1):5-8. 被引量:26
  • 2果德安.中药质量控制研究的思路与方法[J].中国天然药物,2009,7(1):1-1. 被引量:12
  • 3陶燕蓉,陈曦.中药质量评价技术的国内外研究现状及分析[J].中药与临床,2011,2(2):59-62. 被引量:22
  • 4陈汝家,朱俊靖,周盛梅,辛艳飞,宣尧仙,李春启.斑马鱼模型在药物毒性与安全性评价中的应用[J].毒理学杂志,2012,26(3):224-228. 被引量:27
  • 5McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity[ Jl. Drug Discover Today, 2008, 13 (9) : 394401.
  • 6Li CQ, Luo LQ, Awerman J, McGrath P. 2012. Whole Ze- brafish Cytochrome P450 Assays for Assessing Drug Metabolism and Safety. Zebrafish Methods for Assessing Drug Safety and Tox- icity. McGrath P(ed). Wiley Press: New Jersey; 105-115.
  • 7Li CQ, Luo LQ, McGrath P. Zebrafish Xenotransplant Cancer Mode| for Drug Screening. Zebrafish Methods for Assessing Drug Safety and Toxicity. McGrath P (ed). Wiley Press, 2012 : New Jersey ; 219 -232.
  • 8Li, C. Q , Seng, W L. , Park D, & McGrath, P. (2011). Methods for Assessing Neurotoxicity in Zebrafish. Phylonix,Cambridge, MA, USA. In P. McGrath (Ed.), Zebrafish: methods for assessing drug safety and toxicity (pp. 117-134 ).
  • 9West Sussex, UK : Wiley-Balckwell. Clifton JD, Lucumi E, Myers MC, Napper A, Hama K, et al. I- dentification of Novel Inhibitors of Dietary Lipid Absorption Using Zebrafish[J]. PLoS ONE,2010, 5(8) : 1-9.
  • 10Parng C, Seng WL, Semino C, McGrath P. Zebrafish : a preclin- ical model for drug screening. Assay Drug Dev Technol, 2002; 1:41-48.

二级参考文献65

共引文献80

同被引文献171

引证文献9

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部